查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
2018735

心血管针市场：2026-2032年全球市场预测（依产品类型、规格、材质、涂层、最终用户和应用划分）

Cardiovascular Needle Market by Product Type, Gauge, Material, Coating, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 184 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，心血管针头市场价值将达到 9,556 万美元，到 2026 年将成长至 1.0205 亿美元，到 2032 年将达到 1.5,675 亿美元，复合年增长率为 7.32%。

主要市场统计数据
基准年 2025 9556万美元
预计年份：2026年 1.0205亿美元
预测年份 2032 1.5675亿美元
复合年增长率 (%) 7.32%

从策略观点塑造心血管针生态系统的关键临床需求、器材创新方向、监管影响和相关人员需求。

心血管穿刺针市场处于临床需求、医疗设备创新以及不断变化的安全性和监管要求的交汇点。近年来，临床医生和采购团队一直在寻求能够降低手术风险、提高血管通路和心臟介入手术精准度以及改善用户人体工学以实现可重复操作的医疗设备。因此，製造商正在努力平衡传统的机械可靠性与诸如安全功能、更精细的规格选择和先进材料等渐进式创新，以满足临床医生的偏好和患者安全需求。

不断变化的临床安全期望、材料创新和程序转变正在重塑整个心血管针头市场的产品设计重点和供应商策略。

心血管穿刺针市场正经历一场变革，其驱动力包括对临床安全性的更高期望、材料科学的进步以及微创治疗方式的普及。随着医疗系统加强减少针刺伤并遵守职业安全标准，以安全为导向的穿刺针设计日益受到关注。同时，镍钛合金等材料的创新正在改善穿刺针的弯曲性能和抗扭转性能，而硅胶和特殊聚合物等先进涂层则提高了穿刺性能和患者舒适度。

美国近期关税调整如何促使医疗设备製造商和经销商迅速重组其供应链、转移区域采购并投资于增强韧性。

关税政策和贸易调整将对製造商的成本基础和医疗服务提供者的采购决策产生重大影响，尤其是在零件和成品在生产和分销过程中跨境运输的情况下。 2025年，美国实施的新关税措施将给整个供应链带来压力，迫使製造商重新评估其筹资策略、库存布局和短期定价策略，以维持稳定的利润率和市场竞争力。

从详细的细分观点，将产品变化、临床应用、材料和涂层选择与采购趋势和临床医生的决策标准连结起来。

精细化的细分观点能够清楚地揭示产品和临床路径，从而指导产品组合策略和商业化工作。根据产品类型，心血管穿刺针产品组合包括传统穿刺针产品（含自动化穿刺平台）、皮下注射和导引器等，以及配备主动和被动安全机制的安全穿刺针解决方案。在确定每种产品的定位时，了解临床医生的偏好和特定手术需求至关重要。根据最终用户，不同门诊手术中心、诊所和医院的采购趋势和设备使用情况各不相同。这些机构在资本投资週期、库存管理实践和临床医生培训资源方面存在显着差异，从而影响部署计划。

区域市场动态决定了需要製定针对特定区域的商业化策略，以适应世界各地法规、采购行为和製造地的复杂性。

在全球背景下，区域趋势正以不同的方式影响医疗产品的取得、分销和定位。在美洲，大规模医疗系统之间的采购整合以及对职业安全的重视，推动了对安全设计医疗器材和简化合约模式的需求，这些模式支援批量采购和标准化培训项目。相较之下，欧洲、中东和非洲的监管环境各异，采购机制也存在差异，这要求製造商采取灵活的监管策略和区域性的商业性方法，以满足分散的市场进入要求。

主要医疗设备製造商之间的竞争地位取决于技术差异化、临床证据的创造、供应链的灵活性以及有针对性的商业化策略。

心血管针头领域的竞争动态由技术差异化、监管合规性和产品上市能力三者共同决定。主要企业正积极推动内部产品研发和有针对性的伙伴关係，以加速安全功能的整合、材料升级和涂层优化，从而提升临床操作体验。同时，多家企业正加大对品管和上市后监测能力的投入，以验证产品在真实临床环境中的安全性和性能，这为与大型医疗系统和采购集团的合约谈判奠定了基础。

製造商和供应商的具体策略重点，旨在透过产品安全、供应链韧性、临床医生教育和适应性商业模式来促进产品推广。

产业领导企业应采取实际措施，使产品开发、供应链韧性和销售活动与临床医生和采购部门的需求保持一致。首先，他们应优先投资于以安全为中心的设计和涂层，以显着减少插入创伤并改善操作，并透过真实世界的临床评估检验这些说法。其次，他们应促进供应商多元化和区域组装基地的扩张，以降低贸易政策变化带来的风险，并缩短医院和门诊诊所等关键客户的补货週期。

采用透明的混合方法研究途径，结合临床医生访谈、监管审查和供应链分析，为医疗设备策略洞察和建议提供支援。

本研究采用综合分析方法，结合定性专家访谈、临床实践回顾、监管指南分析和供应链评估等多方面调查方法，对心血管穿刺针领域进行了深入剖析。主要研究内容包括与介入医师、采购经理和医疗设备工程师进行结构化讨论，以了解实际应用中的偏好、挑战和推动因素。次要研究内容包括分析法规结构、医疗设备指南和同行评审文献，以检验安全性和性能主题，并将材料和涂层创新置于既定的临床实践背景下进行解读。

策略整合强调需要协调以安全主导的产品创新、证据产生和供应链韧性，以满足不断变化的临床和采购需求。

总而言之，心血管针头市场格局呈现出多方面需求的整合，包括提高安全性、改进材料和涂层，以及增强供应链韧性，以应对不断变化的临床工作流程和行业趋势。能够根据医院、门诊手术中心和诊所的细微需求调整产品蓝图的製造商，将更有利于获得临床医生的支持和采购承诺。强调安全特性、加强临床医生培训以及采用在地化供应策略，对于确保产品被广泛接受和实现可持续的市场进入至关重要。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：心血管针市场：依产品类型划分

  • 自动针
  • 普通针头
  • 安全针

第九章：心血管针头市场（依规格划分）

  • 厚规格
  • 中型轨距
  • 细规格

第十章 心血管穿刺针市场：依材料分类

  • 镍钛
  • 不銹钢

第十一章：心血管针头市场（依涂层分类）

  • 聚合物
  • 硅酮

第十二章 心血管针市场：依最终用户划分

  • 门诊手术中心
  • 诊所
  • 医院

第十三章 心血管针市场：依应用领域划分

  • 麻醉
  • 心血管外科
  • 药物输送
  • 血管通路

第十四章 心血管针市场：依地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章 心血管针市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 心血管针市场：依国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十七章 美国心血管针市场

第十八章 中国心血管针市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Assut Europe Sarl
  • Aurolab
  • B. Braun Melsungen AG
  • Barrett Surgical Needles
  • DemeTECH Corporation
  • FCI Ophthalmics
  • FSSB Surgical Needles
  • Fumis Medical
  • Johnson & Johnson Services, Inc.
  • KLS Martin Group
  • MANI, Inc.
  • Medtronic plc
  • Medtronic plc
  • Peters Surgical
  • RUMEX International
  • Scanlan International, Inc.
  • Serag-Wiessner GmbH
  • Surgical Specialties Corporation
  • Sutures India Pvt. Ltd.
  • Teleflex Incorporated
  • WL Gore & Associates, Inc.
Product Code: MRR-CA17E905E9F5

The Cardiovascular Needle Market was valued at USD 95.56 million in 2025 and is projected to grow to USD 102.05 million in 2026, with a CAGR of 7.32%, reaching USD 156.75 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 95.56 million
Estimated Year [2026] USD 102.05 million
Forecast Year [2032] USD 156.75 million
CAGR (%) 7.32%

A strategic orientation to the critical clinical needs, device innovation vectors, regulatory influences, and stakeholder imperatives shaping the cardiovascular needle ecosystem

The cardiovascular needle landscape is at the intersection of clinical demand, device innovation, and evolving safety and regulatory expectations. In recent years clinicians and procurement teams have sought devices that reduce procedural risk, enhance precision in vascular access and cardiac interventions, and improve user ergonomics for repeatable performance. As a result, manufacturers are balancing traditional mechanical reliability with incremental innovations such as safety features, refined gauge selection, and advanced materials to address clinician preferences and patient safety needs.

Moving forward, stakeholders must navigate a complex ecosystem that includes supplier consolidation, shifting reimbursement priorities in care settings, and heightened attention to occupational safety. Therefore stakeholders should prioritize an evidence-driven understanding of device performance, real-world usability, and post-market surveillance data. This introduction sets the stage for deeper analysis by framing the core clinical imperatives, technological trajectories, and market dynamics that inform strategic decisions across development, procurement, and clinical adoption pathways.

Evolving clinical safety expectations, material innovations, and procedural migration are reshaping product design priorities and supplier strategies across the cardiovascular needle landscape

The cardiovascular needle market is undergoing transformative shifts driven by clinical safety expectations, material science advances, and procedural migration toward less invasive care pathways. Safety-enabled needle designs are gaining prominence as healthcare systems intensify efforts to reduce needlestick injuries and comply with occupational safety standards. Concurrently, materials innovations such as nickel-titanium alloys are enabling improved flexural properties and kink resistance, while refined coatings like silicone and specialty polymers are enhancing insertion performance and patient comfort.

In parallel, care delivery evolution is reshaping demand patterns: a gradual shift of select procedures from inpatient hospital settings to ambulatory surgery centers and clinic-based environments is incentivizing compact, user-friendly devices that support rapid turnover and lower total procedural cost. These converging dynamics are prompting manufacturers to focus on modular product portfolios, targeted clinician training, and differentiated value propositions that emphasize safety, ease of use, and clinical outcomes. As a result, competitive advantage is increasingly tied to integrated offerings that align device attributes with evolving procedural workflows and procurement priorities.

How recent United States tariff adjustments prompted rapid supply chain recalibration, regional sourcing shifts, and resilience investments across device manufacturers and distributors

Tariff policies and trade adjustments can materially affect the cost base for manufacturers and the procurement calculus for healthcare providers, particularly when components or finished devices cross borders during production and distribution. In 2025, new tariff measures introduced by the United States exerted pressure across supply chains, prompting manufacturers to reassess sourcing strategies, inventory positioning, and near-term pricing approaches to maintain margin stability and market competitiveness.

Consequently, several manufacturers prioritized regional manufacturing realignment and increased use of local suppliers to mitigate exposure to tariff-related cost volatility. At the same time, distributors and large healthcare systems accelerated dialogues with multiple suppliers to secure continuity of supply and negotiate more flexible contract terms. These adaptations drove a renewed focus on supply chain resilience: companies invested in diversified supplier networks, inventory buffering in strategic locations, and more granular cost modeling to pass transparent, defensible pricing to procurement stakeholders while preserving critical device availability for clinical teams.

In-depth segmentation perspective linking product variants, clinical applications, and material and coating choices to procurement dynamics and clinician decision criteria

A granular segmentation lens reveals distinct product and clinical pathways that should guide portfolio strategy and commercialization efforts. Based on product type, cardiovascular needle portfolios span automatic needle platforms, conventional needle offerings that include both hypodermic and introducer variants, and safety needle solutions that encompass active and passive safety mechanisms; understanding clinician preference and procedure-specific requirements is essential when positioning each variant. Based on end user, purchasing dynamics and device utilization differ across ambulatory surgery centers, clinics, and hospitals, where capital procurement cycles, inventory practices, and clinician training resources vary significantly and influence adoption timelines.

Based on application, device design and performance expectations diverge for anesthesia procedures, cardiovascular surgery, drug delivery applications, and vascular access interventions, requiring manufacturers to align features with procedure-specific performance criteria. Based on gauge, clinical selection between large, medium, and small gauges reflects trade-offs in flow characteristics, tissue trauma, and device handling that materially influence clinician choice. Based on material, the selection between nickel titanium and stainless steel impacts mechanical performance, fatigue resistance, and sterilization considerations. Based on coating, uncoated needles and those with polymer or silicone finishes present different insertion profiles and patient comfort attributes. Integrating these segmentation views into R&D, regulatory strategy, and field education programs enables targeted value propositions that address differentiated clinical and procurement needs.

Regional market dynamics demand tailored commercialization strategies that align regulatory complexity, procurement behaviors, and manufacturing footprints across global territories

Regional dynamics shape access, distribution, and product positioning in distinct ways across the global landscape. In the Americas, procurement consolidation among large healthcare systems and a strong emphasis on occupational safety drive demand for safety-engineered devices and simplified contract models that support large-volume purchasing and standardized training programs. In contrast, Europe, Middle East & Africa exhibit diverse regulatory landscapes and heterogeneous procurement mechanisms, prompting manufacturers to adopt flexible regulatory strategies and localized commercial approaches to meet fragmented market access requirements.

The Asia-Pacific region continues to be characterized by rapid adoption of minimally invasive techniques, a growing private healthcare sector, and increasing local manufacturing capabilities that together create both opportunity and competitive pressure for multinational suppliers. These regional contrasts necessitate differentiated go-to-market strategies, including region-specific clinical evidence generation, localized manufacturing or assembly where appropriate, and tailored commercial models that reflect payer structures and procurement norms in each geography.

Competitive positioning driven by engineering differentiation, clinical evidence generation, supply chain agility, and targeted commercialization tactics among leading device manufacturers

Competitive dynamics in the cardiovascular needle arena are shaped by a combination of engineering differentiation, regulatory compliance, and go-to-market execution. Leading players pursue a mix of organic product development and targeted partnerships to accelerate safety feature integration, material upgrades, and coating optimizations that improve clinical handling. At the same time, several firms are investing in quality management and post-market surveillance capabilities to demonstrate real-world safety and performance, which supports contracting conversations with major health systems and procurement groups.

Additionally, strategic distribution partnerships and selective regional manufacturing investments are common tactics to reduce lead times and tariff exposure while enhancing service responsiveness. Companies that succeed tend to combine robust clinical evidence packages with flexible commercial models, clinician education initiatives, and responsive supply chain practices that together create defensible differentiation in both institutional tenders and point-of-care adoption scenarios. For new entrants, focused niche strategies-such as specialized introducer needles or premium-coated drug-delivery variants-can unlock clinical advocacy when paired with targeted outcomes data and practical training support.

Actionable strategic priorities for manufacturers and suppliers to drive adoption through product safety, supply chain resilience, clinician education, and adaptive commercial models

Industry leaders should take pragmatic steps to align product development, supply chain resilience, and commercial outreach with clinician and procurement needs. First, prioritize investment in safety-enabled designs and coatings that demonstrably reduce insertion trauma and improve handling, while concurrently validating those claims through real-world clinical evaluations. Next, pursue supplier diversification and regional assembly footprints to reduce exposure to trade policy shifts and to shorten replenishment cycles for critical hospital and ambulatory customers.

Furthermore, focus commercial efforts on building clinician trust through structured education programs, case-based evidence dissemination, and collaborative pilot initiatives that facilitate early adoption. Align pricing and contracting strategies with the procurement realities of hospitals, ambulatory surgery centers, and clinics by offering flexible purchasing models and clear value justification tied to safety and procedural efficiency. Finally, integrate post-market feedback loops into product roadmaps to continuously refine device ergonomics and performance in response to clinician insights, thereby maintaining a sustainable competitive edge in a rapidly evolving clinical environment.

A transparent mixed-methods research approach integrating clinician interviews, regulatory review, and supply chain analysis to underpin strategic device insights and recommendations

This research synthesis draws on a multi-source methodology that combines qualitative expert interviews, clinical practice reviews, regulatory guidance analysis, and supply chain assessment to generate a robust perspective on the cardiovascular needle domain. Primary inputs included structured discussions with interventional clinicians, procurement leaders, and device engineers to capture real-world preferences, pain points, and adoption drivers. Secondary inputs encompassed analysis of regulatory frameworks, device guidance, and peer-reviewed literature to validate safety and performance themes and to contextualize material and coating innovations within accepted clinical practice.

Analytical steps included cross-referencing clinician-reported needs with product feature sets, mapping procurement behaviors across hospital, ambulatory surgery center, and clinic settings, and evaluating supply chain risk under recent tariff scenarios to assess resilience strategies. Findings were synthesized to highlight actionable implications for product design, market entry, and commercial execution, and to identify areas where further targeted clinical evaluation or pilot deployment would meaningfully reduce adoption friction and support contracting discussions.

Strategic synthesis highlighting the imperative to align safety-driven product innovation, evidence generation, and supply chain resilience to meet evolving clinical and procurement demands

In summary, the cardiovascular needle landscape is defined by converging demands for enhanced safety, material and coating refinement, and supply chain resilience in response to shifting clinical workflows and trade dynamics. Manufacturers that align their product roadmaps with the nuanced needs of hospitals, ambulatory surgery centers, and clinics will be better positioned to secure clinician advocacy and procurement commitments. Emphasizing safety features, clinician training, and localized supply strategies will be critical levers for adoption and sustained market access.

Looking ahead, continued collaboration between manufacturers, clinicians, and procurement teams will accelerate the translation of incremental device improvements into measurable clinical and operational benefits. By maintaining a rigorous focus on evidence generation, flexible commercial approaches, and responsive supply chain design, stakeholders can navigate policy headwinds and evolving care models while delivering devices that meet the highest standards of safety and performance.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Cardiovascular Needle Market, by Product Type

  • 8.1. Automatic Needle
  • 8.2. Conventional Needle
  • 8.3. Safety Needle

9. Cardiovascular Needle Market, by Gauge

  • 9.1. Large Gauge
  • 9.2. Medium Gauge
  • 9.3. Small Gauge

10. Cardiovascular Needle Market, by Material

  • 10.1. Nickel Titanium
  • 10.2. Stainless Steel

11. Cardiovascular Needle Market, by Coating

  • 11.1. Polymer
  • 11.2. Silicone

12. Cardiovascular Needle Market, by End User

  • 12.1. Ambulatory Surgery Center
  • 12.2. Clinics
  • 12.3. Hospitals

13. Cardiovascular Needle Market, by Application

  • 13.1. Anesthesia
  • 13.2. Cardiovascular Surgery
  • 13.3. Drug Delivery
  • 13.4. Vascular Access

14. Cardiovascular Needle Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Cardiovascular Needle Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Cardiovascular Needle Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Cardiovascular Needle Market

18. China Cardiovascular Needle Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Assut Europe Sarl
  • 19.6. Aurolab
  • 19.7. B. Braun Melsungen AG
  • 19.8. Barrett Surgical Needles
  • 19.9. DemeTECH Corporation
  • 19.10. FCI Ophthalmics
  • 19.11. FSSB Surgical Needles
  • 19.12. Fumis Medical
  • 19.13. Johnson & Johnson Services, Inc.
  • 19.14. KLS Martin Group
  • 19.15. MANI, Inc.
  • 19.16. Medtronic plc
  • 19.17. Medtronic plc
  • 19.18. Peters Surgical
  • 19.19. RUMEX International
  • 19.20. Scanlan International, Inc.
  • 19.21. Serag-Wiessner GmbH
  • 19.22. Surgical Specialties Corporation
  • 19.23. Sutures India Pvt. Ltd.
  • 19.24. Teleflex Incorporated
  • 19.25. W.L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL CARDIOVASCULAR NEEDLE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL CARDIOVASCULAR NEEDLE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AUTOMATIC NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AUTOMATIC NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AUTOMATIC NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CONVENTIONAL NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CONVENTIONAL NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CONVENTIONAL NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SAFETY NEEDLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SAFETY NEEDLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SAFETY NEEDLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY LARGE GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY LARGE GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY LARGE GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MEDIUM GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MEDIUM GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MEDIUM GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SMALL GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SMALL GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SMALL GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY NICKEL TITANIUM, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY NICKEL TITANIUM, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY NICKEL TITANIUM, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY STAINLESS STEEL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY POLYMER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY POLYMER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY POLYMER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SILICONE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SILICONE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY SILICONE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY AMBULATORY SURGERY CENTER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY ANESTHESIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY ANESTHESIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY ANESTHESIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY CARDIOVASCULAR SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY DRUG DELIVERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY VASCULAR ACCESS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY VASCULAR ACCESS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY VASCULAR ACCESS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 61. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 62. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 63. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 64. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 65. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 66. AMERICAS CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 67. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 69. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 70. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 71. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 72. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 73. NORTH AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 74. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 76. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 77. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 78. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 79. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 80. LATIN AMERICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 83. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 84. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 85. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 86. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 87. EUROPE, MIDDLE EAST & AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 88. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 90. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 91. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 92. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 93. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 94. EUROPE CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 95. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 98. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 99. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 100. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. MIDDLE EAST CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 102. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 104. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 105. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 106. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 107. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AFRICA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 111. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 112. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 113. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 114. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 115. ASIA-PACIFIC CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 119. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 120. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 121. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 122. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 123. ASEAN CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 124. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 126. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 127. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 128. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 129. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 130. GCC CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPEAN UNION CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 138. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 140. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 141. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 142. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 143. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. BRICS CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 148. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 149. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 150. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 151. G7 CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 155. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 156. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 157. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. NATO CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL CARDIOVASCULAR NEEDLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 161. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 162. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 163. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 164. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 165. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 166. UNITED STATES CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 167. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY GAUGE, 2018-2032 (USD MILLION)
  • TABLE 170. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
  • TABLE 171. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY COATING, 2018-2032 (USD MILLION)
  • TABLE 172. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. CHINA CARDIOVASCULAR NEEDLE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)